#antibody-design

[ follow ]
Startup companies
fromTechCrunch
1 day ago

OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation | TechCrunch

Chai Discovery raised a $130 million Series B at a $1.3 billion valuation to advance AI-driven molecular design; Chai 2 improves de novo antibody design.
[ Load more ]